Open AccessViral resistance may limit the benefit of neuraminidase inhibitors therapy during an influenza pandemic
Author(s) -
Nathanaël Lapidus,
Magali Lemaître,
Fabrice Carrat
Publication year - 2007
Publication title -
hal (le centre pour la communication scientifique directe)
Language(s) - English
Resource type - Conference proceedings
Subject(s) - neuraminidase , pandemic , virology , neuraminidase inhibitor , pandemic influenza , limit (mathematics) , resistance (ecology) , covid-19 , medicine , biology , virus , disease , infectious disease (medical specialty) , mathematics , mathematical analysis , ecology